Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricTEVATeva Pharmaceutical Industries LtdZTSZoetisHLNHaleon PLC
Snapshot
Price$37.18$75.62$9.89
Market cap$32.95B$33.26B$40.75B
Valuation
P/E25.8x12.1x19x
Forward P/E—11.2x16.2x
Growth
Revenue growth4.4%2.4%-1.8%
EPS growth—8.4%17.6%
Profitability
Net margin9.0%27.8%15.1%
ROE20.7%62.4%10.3%
Balance sheet & cash
Debt / equity2.12x2.72x0.52x
Free cash flow yield-10.5%7.5%0.5%
Dividend yield—1.6%1.9%
Verdict
Investment ratingWeak· 33Favorable· 63Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearTEVAtoday $37ZTStoday $76HLNtoday $10
2027$29.11 – $42.70+15% CAGR$61.47 – $90.16+19% CAGR$8.72 – $12.79+29% CAGR
2028$30.40 – $44.58+10% CAGR$66.63 – $97.73+14% CAGR$10.25 – $15.04+23% CAGR
2029$31.74 – $46.55+8% CAGR$72.22 – $105.92+12% CAGR$12.05 – $17.68+21% CAGR
2030$33.14 – $48.60+7% CAGR$78.28 – $114.81+11% CAGR$14.17 – $20.79+20% CAGR
2031$34.60 – $50.75+6% CAGR$84.85 – $124.44+10% CAGR$16.66 – $24.44+20% CAGR
5-yr CAGR-1.4% – 6.4%2.3% – 10.5%11.0% – 19.8%